Page 59 - Read Online
P. 59

Boyajian et al. Microbiome Res Rep 2024;3:29  https://dx.doi.org/10.20517/mrr.2024.05  Page 13 of 35






























                Figure 2. Schematic representation of the inflammatory pathway from the gut to adipose tissue and the resulting consequences on
                human health. LPS: Lipopolysaccharide; LBP: lipopolysaccharide binding protein; CD14: cluster of differentiation 14; NF-κB: nuclear factor
                kappa B.

               protein (e.g., occludin), and an increase in cecum and serum levels of LPS were found in the mice. Further
               investigation of vagal activity in metabolically compromised models is warranted to determine its role in
               obesity and related diseases.

               The vagus nerve is also proposed to play a role in aging. Dystrophic remodeling of vagal afferents in the GI
               may occur with age, leading to decreased vagal stimulation . Moreover, the vagus nerve may be involved
                                                                 [112]
               in the development of neurodegenerative diseases, such as Parkinson’s Disease (PD), through the
               misfolding of α-synuclein, a protein that leads to the formation of Lewy bodies that are present in neurons
               in PD individuals . In AD patients, a dysbiotic gut and associated intestinal barrier disruption can induce
                              [113]
               neuroinflammation and aggravate amyloid  β (Aβ) plaque formation, a known biomarker of AD.
               Considering the similarity between α-synuclein and Aβ pathologies, the vagus nerve has been speculated to
               play a role in AD similar to that of PD [113,114] . Thus, the link between obesity and aging may be explained, in
               part, by the GBA through altered vagal signaling and associated inflammation. However, additional studies
               are needed to clarify the role of the vagus nerve in obesity, aging, and the GBA.


               CURRENT STRATEGIES FOR TREATING OBESITY AND AGING
               Lifestyle modifications
               Weight loss is achieved when an energy deficit occurs . Energy expenditure can be increased through
                                                              [115]
               physical activity, while dieting may reduce energy intake. Thus, the first line of therapy for obesity regards
               lifestyle modifications to promote exercise and healthy dietary habits. Expert guidelines recommend an
               initial prescription of moderate aerobic activity of at least 150 min per week. Combining exercise with
               reduced caloric results in an additional 1% to 3% of body weight, with intensity of physical activity positively
               correlated with reduced body fat and maintained muscle mass . Restricting calories through nutritionally
                                                                    [116]
               balanced low-energy diets (800-1,800 kcal/day) or very low-energy diets (less than 800 kcal/day) are
               commonly prescribed for weight loss . Low-calorie diets with different macronutrient profiles have
                                                [117]
               demonstrated successful treatment of obesity, including ketogenic and Mediterranean diets [118,119] . High-
               protein calorie restriction diets may also be effective in reducing weight and beneficially modulating the gut
   54   55   56   57   58   59   60   61   62   63   64